Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826)
23.55
+0.20 (0.86%)
May 14, 2025, 1:44 PM HKT
HKG:6826 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | May '25 May 13, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Market Capitalization | 11,436 | 13,346 | 17,596 | 16,428 | 23,247 | 16,570 | Upgrade
|
Market Cap Growth | -17.48% | -24.15% | 7.11% | -29.33% | 40.30% | 5.18% | Upgrade
|
Enterprise Value | 9,371 | 11,268 | 15,426 | 14,028 | 20,392 | 13,500 | Upgrade
|
Last Close Price | 23.35 | 26.65 | 27.64 | 24.93 | 34.04 | 30.76 | Upgrade
|
PE Ratio | 12.28 | 29.83 | 38.38 | 80.52 | 53.77 | 60.64 | Upgrade
|
Forward PE | 8.89 | 8.02 | 8.02 | 8.02 | 8.02 | 8.02 | Upgrade
|
PS Ratio | 4.02 | 4.68 | 6.06 | 6.82 | 10.82 | 10.54 | Upgrade
|
PB Ratio | 1.79 | 2.12 | 2.65 | 2.46 | 3.13 | 2.43 | Upgrade
|
P/TBV Ratio | 2.34 | 2.73 | 3.43 | 3.36 | 4.04 | 2.97 | Upgrade
|
P/FCF Ratio | 27.45 | 44.10 | 43.30 | - | 265.24 | 192.78 | Upgrade
|
P/OCF Ratio | 16.20 | 19.34 | 25.17 | 62.83 | 55.33 | 53.24 | Upgrade
|
EV/Sales Ratio | 3.30 | 3.95 | 5.31 | 5.83 | 9.49 | 8.58 | Upgrade
|
EV/EBITDA Ratio | 15.21 | 19.29 | 24.77 | 35.19 | 50.04 | 55.13 | Upgrade
|
EV/EBIT Ratio | 23.63 | 28.46 | 35.74 | 71.04 | 84.37 | 122.46 | Upgrade
|
EV/FCF Ratio | 22.49 | 37.23 | 37.96 | - | 232.66 | 157.06 | Upgrade
|
Debt / Equity Ratio | 0.08 | 0.08 | 0.07 | 0.02 | 0.02 | 0.02 | Upgrade
|
Debt / EBITDA Ratio | 0.79 | 0.78 | 0.69 | 0.32 | 0.30 | 0.48 | Upgrade
|
Debt / FCF Ratio | 1.17 | 1.58 | 1.11 | - | 1.48 | 1.49 | Upgrade
|
Asset Turnover | 0.37 | 0.38 | 0.38 | 0.31 | 0.26 | 0.21 | Upgrade
|
Inventory Turnover | 1.63 | 1.66 | 1.56 | 1.61 | 1.61 | 1.35 | Upgrade
|
Quick Ratio | 3.58 | 3.57 | 4.35 | 5.76 | 6.78 | 7.98 | Upgrade
|
Current Ratio | 4.25 | 4.22 | 5.24 | 6.91 | 7.62 | 8.78 | Upgrade
|
Return on Equity (ROE) | 6.09% | 6.30% | 6.92% | 3.18% | 5.89% | 3.98% | Upgrade
|
Return on Assets (ROA) | 3.22% | 3.27% | 3.50% | 1.58% | 1.86% | 0.93% | Upgrade
|
Return on Capital (ROIC) | 3.56% | 3.64% | 3.94% | 1.79% | 2.05% | 1.00% | Upgrade
|
Return on Capital Employed (ROCE) | 5.90% | 5.90% | 6.10% | 2.70% | 3.00% | 1.60% | Upgrade
|
Earnings Yield | 3.87% | 3.35% | 2.60% | 1.24% | 1.86% | 1.65% | Upgrade
|
FCF Yield | 3.64% | 2.27% | 2.31% | -0.59% | 0.38% | 0.52% | Upgrade
|
Dividend Yield | 5.48% | 3.99% | 2.03% | 1.30% | 1.80% | 1.38% | Upgrade
|
Payout Ratio | 62.71% | 61.80% | 16.46% | 70.31% | 24.96% | 53.92% | Upgrade
|
Buyback Yield / Dilution | -10.53% | 1.77% | 30.23% | 1.47% | 0.62% | -8.72% | Upgrade
|
Total Shareholder Return | -5.05% | 5.76% | 32.26% | 2.77% | 2.43% | -7.34% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.